Filtros de búsqueda

Lista de obras de

Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer

artículo científico publicado en 2014

Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment in patients with metastatic breast cancer.

artículo científico publicado en 2015

Comparing time to disease progression of irinotecan and oxaliplatin-based chemotherapies in colorectal cancer patients with liver only metastasis.

artículo científico publicado en 2013

Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines

artículo científico publicado en 2014

Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer.

artículo científico publicado en 2010

Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315

scientific article published on 15 May 2015

The frequency and significance of radiologically detected indeterminate pulmonary nodules in patients with colorectal cancer.

artículo científico publicado en 2012

Undifferentiated embryonal sarcoma of the liver in an adult patient: case report

artículo científico publicado en 2012

Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.

artículo científico publicado en 2012

Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines

artículo científico publicado en 2014